Madeline Whitlock

Publications (3)

Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5-Subtype Selective GABA

Clinical pharmacology in drug development

Avec: Rachel Gurrell , Mark Whitlock , Hua Wei , Zhongzhou Shen , Adam Ogden

Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABA

British journal of anaesthesia

Avec: Guido van Amerongen , Pieter S Siebenga , Rachel Gurrell , Pinky Dua , Mark Whitlock , Donal Gorman , Pieter Okkerse , Justin L Hay , Richard P Butt , Geert Jan Groeneveld

A phase 2a, randomized, double-blind, placebo-controlled, three-arm, parallel-group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF-06835919 in patients with non-alcoholic fatty liver disease and type 2 diabetes.

Diabetes, obesity & metabolism

Avec: Aditi R Saxena , Stephanie-An Lyle , Kaivan Khavandi , Ruolun Qiu , Mark Whitlock , William P Esler , Albert M Kim

Réseau de co-auteurs

Mark Whitlock 3 collaborations

Rachel Gurrell 2 collaborations

Hua Wei 1 collaboration

Zhongzhou Shen 1 collaboration

Adam Ogden 1 collaboration

Guido van Amerongen 1 collaboration

Pieter S Siebenga 1 collaboration

Pinky Dua 1 collaboration

Donal Gorman 1 collaboration

Pieter Okkerse 1 collaboration

Justin L Hay 1 collaboration

Richard P Butt 1 collaboration

Geert Jan Groeneveld 1 collaboration

Aditi R Saxena 1 collaboration

Stephanie-An Lyle 1 collaboration

Kaivan Khavandi 1 collaboration

Ruolun Qiu 1 collaboration

William P Esler 1 collaboration

Albert M Kim 1 collaboration